Menstrual and reproductive history, postmenopausal hormone use, and risk of benign proliferative epithelial disorders of the breast

A cohort study

Yan Cui, David L. Page, Dorothy S. Lane, Thomas E. Rohan

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Menstrual and reproductive history and postmenopausal hormone use are well-established risk factors for breast cancer. However, previous studies that have assessed these factors in association with risk of benign proliferative epithelial disorders (BPED) of the breast, putative precursors of breast cancer, have yielded inconsistent findings. To investigate these associations, we conducted a cohort study among 68,132 postmenopausal women enrolled in the Women's Health Initiative randomized clinical trials. Women were prospectively followed and those reporting an open surgical biopsy or a core needle biopsy had histological sections obtained for centralized pathology review. Over an average of 7.8 years of follow-up, we identified 1,792 women with BPED of the breast. We used Cox proportional hazards models to estimate hazard ratios (HRs) and 95% confidence limits (CLs) for the associations of interest. Menstrual and reproductive histories were not associated with risk of BPED of the breast, overall or by histological subtype. Women who had used postmenopausal hormones for 15 years or more had a two-fold increase in risk of BPED of the breast compared to women who had never used postmenopausal hormones (HR = 2.03 95% CL = 1.73, 2.38) and the increase in risk was observed for both BPED of the breast without atypia and for atypical hyperplasia. Furthermore, the risk of BPED of the breast decreased with time since cessation of use so that there was essentially no increase in risk 5 or more years after ending use (HR for stopping ≥5 years earlier = 0.96, 95%CL = 0.79, 1.16; HR for stopping <5 years earlier = 1.32, 95% CL = 1.08,1.61).

Original languageEnglish (US)
Pages (from-to)113-120
Number of pages8
JournalBreast Cancer Research and Treatment
Volume114
Issue number1
DOIs
StatePublished - Mar 2009

Fingerprint

Reproductive History
Breast
Cohort Studies
Hormones
Breast Neoplasms
Large-Core Needle Biopsy
Women's Health
Proportional Hazards Models
Hyperplasia
Randomized Controlled Trials
Pathology
Biopsy

Keywords

  • Benign proliferative epithelial disorders of the breast
  • Menstrual history
  • Postmenopausal hormone use
  • Reproductive history

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Menstrual and reproductive history, postmenopausal hormone use, and risk of benign proliferative epithelial disorders of the breast : A cohort study. / Cui, Yan; Page, David L.; Lane, Dorothy S.; Rohan, Thomas E.

In: Breast Cancer Research and Treatment, Vol. 114, No. 1, 03.2009, p. 113-120.

Research output: Contribution to journalArticle

@article{a03bad03183f45268bd72cf0b877d48d,
title = "Menstrual and reproductive history, postmenopausal hormone use, and risk of benign proliferative epithelial disorders of the breast: A cohort study",
abstract = "Menstrual and reproductive history and postmenopausal hormone use are well-established risk factors for breast cancer. However, previous studies that have assessed these factors in association with risk of benign proliferative epithelial disorders (BPED) of the breast, putative precursors of breast cancer, have yielded inconsistent findings. To investigate these associations, we conducted a cohort study among 68,132 postmenopausal women enrolled in the Women's Health Initiative randomized clinical trials. Women were prospectively followed and those reporting an open surgical biopsy or a core needle biopsy had histological sections obtained for centralized pathology review. Over an average of 7.8 years of follow-up, we identified 1,792 women with BPED of the breast. We used Cox proportional hazards models to estimate hazard ratios (HRs) and 95{\%} confidence limits (CLs) for the associations of interest. Menstrual and reproductive histories were not associated with risk of BPED of the breast, overall or by histological subtype. Women who had used postmenopausal hormones for 15 years or more had a two-fold increase in risk of BPED of the breast compared to women who had never used postmenopausal hormones (HR = 2.03 95{\%} CL = 1.73, 2.38) and the increase in risk was observed for both BPED of the breast without atypia and for atypical hyperplasia. Furthermore, the risk of BPED of the breast decreased with time since cessation of use so that there was essentially no increase in risk 5 or more years after ending use (HR for stopping ≥5 years earlier = 0.96, 95{\%}CL = 0.79, 1.16; HR for stopping <5 years earlier = 1.32, 95{\%} CL = 1.08,1.61).",
keywords = "Benign proliferative epithelial disorders of the breast, Menstrual history, Postmenopausal hormone use, Reproductive history",
author = "Yan Cui and Page, {David L.} and Lane, {Dorothy S.} and Rohan, {Thomas E.}",
year = "2009",
month = "3",
doi = "10.1007/s10549-008-9973-9",
language = "English (US)",
volume = "114",
pages = "113--120",
journal = "Breast Cancer Research and Treatment",
issn = "0167-6806",
publisher = "Springer New York",
number = "1",

}

TY - JOUR

T1 - Menstrual and reproductive history, postmenopausal hormone use, and risk of benign proliferative epithelial disorders of the breast

T2 - A cohort study

AU - Cui, Yan

AU - Page, David L.

AU - Lane, Dorothy S.

AU - Rohan, Thomas E.

PY - 2009/3

Y1 - 2009/3

N2 - Menstrual and reproductive history and postmenopausal hormone use are well-established risk factors for breast cancer. However, previous studies that have assessed these factors in association with risk of benign proliferative epithelial disorders (BPED) of the breast, putative precursors of breast cancer, have yielded inconsistent findings. To investigate these associations, we conducted a cohort study among 68,132 postmenopausal women enrolled in the Women's Health Initiative randomized clinical trials. Women were prospectively followed and those reporting an open surgical biopsy or a core needle biopsy had histological sections obtained for centralized pathology review. Over an average of 7.8 years of follow-up, we identified 1,792 women with BPED of the breast. We used Cox proportional hazards models to estimate hazard ratios (HRs) and 95% confidence limits (CLs) for the associations of interest. Menstrual and reproductive histories were not associated with risk of BPED of the breast, overall or by histological subtype. Women who had used postmenopausal hormones for 15 years or more had a two-fold increase in risk of BPED of the breast compared to women who had never used postmenopausal hormones (HR = 2.03 95% CL = 1.73, 2.38) and the increase in risk was observed for both BPED of the breast without atypia and for atypical hyperplasia. Furthermore, the risk of BPED of the breast decreased with time since cessation of use so that there was essentially no increase in risk 5 or more years after ending use (HR for stopping ≥5 years earlier = 0.96, 95%CL = 0.79, 1.16; HR for stopping <5 years earlier = 1.32, 95% CL = 1.08,1.61).

AB - Menstrual and reproductive history and postmenopausal hormone use are well-established risk factors for breast cancer. However, previous studies that have assessed these factors in association with risk of benign proliferative epithelial disorders (BPED) of the breast, putative precursors of breast cancer, have yielded inconsistent findings. To investigate these associations, we conducted a cohort study among 68,132 postmenopausal women enrolled in the Women's Health Initiative randomized clinical trials. Women were prospectively followed and those reporting an open surgical biopsy or a core needle biopsy had histological sections obtained for centralized pathology review. Over an average of 7.8 years of follow-up, we identified 1,792 women with BPED of the breast. We used Cox proportional hazards models to estimate hazard ratios (HRs) and 95% confidence limits (CLs) for the associations of interest. Menstrual and reproductive histories were not associated with risk of BPED of the breast, overall or by histological subtype. Women who had used postmenopausal hormones for 15 years or more had a two-fold increase in risk of BPED of the breast compared to women who had never used postmenopausal hormones (HR = 2.03 95% CL = 1.73, 2.38) and the increase in risk was observed for both BPED of the breast without atypia and for atypical hyperplasia. Furthermore, the risk of BPED of the breast decreased with time since cessation of use so that there was essentially no increase in risk 5 or more years after ending use (HR for stopping ≥5 years earlier = 0.96, 95%CL = 0.79, 1.16; HR for stopping <5 years earlier = 1.32, 95% CL = 1.08,1.61).

KW - Benign proliferative epithelial disorders of the breast

KW - Menstrual history

KW - Postmenopausal hormone use

KW - Reproductive history

UR - http://www.scopus.com/inward/record.url?scp=58849143074&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58849143074&partnerID=8YFLogxK

U2 - 10.1007/s10549-008-9973-9

DO - 10.1007/s10549-008-9973-9

M3 - Article

VL - 114

SP - 113

EP - 120

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 1

ER -